🇺🇸 FDA
Patent

US 8440721

Methods for concomitant administration of colchicine and a second active agent

granted A61KA61K31/165A61K31/496

Quick answer

US patent 8440721 (Methods for concomitant administration of colchicine and a second active agent) held by Takeda Pharmaceuticals U.S.A., Inc. expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceuticals U.S.A., Inc.
Grant date
Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/165, A61K31/496, A61P, A61P19/02